Human medicines European public assessment report (EPAR): Kanuma, sebelipase alfa, Date of authorisation: 28/08/2015, Revision: 11, Status: Authorised

Committee for Advanced Therapies (CAT): 18-20 February 2026, European Medicines Agency, Amsterdam, the Netherlands, from 18 February 2026 to 20 February 2026

Bioabsorbable orthopaedic screws - Notified body 0344 - 14/05/2024 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Minutes – Ad hoc Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 5 March 2026

Minutes – Ad hoc Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 5 March 2026

Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Jardiance, empagliflozin, Date of authorisation: 22/05/2014, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Velphoro, sucroferric oxyhydroxide, Date of authorisation: 26/08/2014, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Zynyz, retifanlimab, Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised

Medicine shortage communications (MSC)